VERA Price Prediction Next Week
VERA Stock Price Prediction and Recommendation
News Analysis:
- Wells Fargo Insight: VERA shares dropped 20% due to competitor Otsuka's announcement but is seen as a buying opportunity with a $70 target.
- Goldman Sachs View: Shares dropped 18% post Otsuka's earnings, deemed an overreaction, maintaining a Buy rating.
- Wolfe Research Initiation: Initiated with Outperform and $49 target.
Technical Indicators:
- RSI: Oversold at 32.24 (6-period), indicating potential rebound.
- MACD: Negative but nearing bullish crossover.
- Fibonacci Levels: Support at $26.96, resistance at $28.99.
- Volume: Decreasing, suggesting weakening selling pressure.
- SMA: Below key moving averages, indicating bearish trend but possible bounce.
Price Prediction:
- Target Price: $28.50
- Recommendation: Buy
Graphical Components:
VERA Similar Chart Price Prediction
The price of VERA is predicted to go up -20.37%, based on the high correlation periods with KZR. The similarity of these two price pattern on the periods is 96.62%.
VERA
KZR
Down: -20.37%Similarity: 96.62%
VERA Revenue Forecast
VERA EPS Forecast
VERA Analyst's Forecast
Anupam Rama
JP Morgan
Buy
2025-03-04
Price Target
$77 → $71
Upside
+148.25%
JPMorgan analyst Anupam Rama lowered the firm's price target on Vera Therapeutics to $71 from $77 and keeps an Overweight rating on the shares. The firm updated models in the Smid-cap biotechnology group post the Q4 reports.
Mohit Bansal
Wells Fargo
Buy
2024-11-21
Price Target
$70
Upside
+44.9%
Anupam Rama
JP Morgan
Buy
2024-11-05
Price Target
$72 → $75
Upside
+57.23%
